India Emerges as the Fourth Global Research Hub
According to a recent analysis, India has become a prominent centre for academic research globally, securing the fourth position worldwide in terms of academic...
IOC Bags Over One-Third of D6 Gas in Reliance Auction
In the latest auction of natural gas from the KG-D6 block by Reliance Industries Ltd and its partner BP, Indian Oil Corporation (IOC) acquired...
Mahindra Susten Planning Hybrid Renewable Energy Project
Mahindra Group unveiled its ambitious plans to develop a hybrid renewable energy venture integrating solar and wind power, boasting a capacity of about 150...
TPSSL and NTPC Sign Deal for Solar Module Supply
Tata Power Solar Systems Limited (TPSSL) secured a contract from NTPC Limited to supply 152 MWp solar PV modules for the Nokh solar project...
Strengthening India’s Pharmaceutical Manufacturing by Addressing Vulnerabilities in the Supply Chain
After three decades, India is set to resume the manufacturing of Penicillin G., attributing the achievement to the success of the government’s Production Linked...
Yara to Acquire Agribios Italiana’s Fertilizer Business
Yara is acquiring the organic-based fertilizer business of Agribios Italiana, the company’s second bolt-on acquisition supporting its organic strategy in Europe. The take over...
SAMSUNG E&A Bags Aramco Fadhili Gas Project Contract
SAMSUNG E&A, an engineering solutions and project management company, bagged approximately $6 billion worth contracts for Fadhili Gas Increment Program from Aramco. The Fadhili...
ITT Expanding Pump Testing Initiatives in Germany, India, and Saudi Arabia
Investments are underway at facilities located in Obernkirchen, Germany, Vadodara, India, and Dammam, Saudi Arabia, aimed at expanding ITT’s power capacity for testing pump,...
ONGC Progressing on Developing Blueprint for Second-Deepest Offshore Gas Discovery Worldwide
Oil & Natural Gas Corporation (ONGC) is set to present the field development plan (FDP) for the second deepest hydrocarbon discovery globally, located in...
Biocon Considering Sale of Generic API Business
Biocon is contemplating the sale of its generic active pharmaceutical ingredient (API) business, valued at around $1.5 billion, as part of a strategic move...
Advertisement
Newsletter
Subscribe to our FREE Newsletter & Stay Updated
